Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-07 Purchase | 2023-11-09 8:32 pm | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) | View |
| 2023-02-06 Purchase | 2023-02-08 7:40 pm | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) | View |
| 2022-02-10 Purchase | 2022-04-05 07:24 am | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) | View |
| 2021-05-18 Purchase | 2021-05-18 8:20 pm | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) | View |
| 2020-10-20 Purchase | 2020-10-22 8:24 pm | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner | 233,333 | $18 | $4,199,994 | 3,918,691 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-07 Conversion | 2023-11-09 8:32 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 24,018,702 | $0 | 2,567,100 (Indirect) | View |
Ownership | 2023-11-02 9:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,067,743 (Indirect) | View |
| 2021-05-18 Conversion | 2021-05-18 8:20 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 2,187,504 | $0 | 3,096,594 (Indirect) | View |
Ownership | 2021-05-13 7:27 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2021-04-14 Other | 2021-04-15 9:00 pm | N/A N/A | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. Longitude Capital Partners IV LLC ENRIGHT PATRICK G 10% Owner | 1,005,012 | $0 | 3,928,715 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 8:24 pm | N/A N/A | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner | 3,685,358 | $0 | 3,918,691 (Direct) | View |